Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Interest & Investment Income (2016 - 2025)

Tandem Diabetes Care filings provide 13 years of Interest & Investment Income readings, the most recent being $4.2 million for Q1 2025.

  • On a quarterly basis, Interest & Investment Income fell 21.1% to $4.2 million in Q1 2025 year-over-year; TTM through Mar 2025 was $16.9 million, a 24.36% decrease, with the full-year FY2024 number at $18.0 million, down 21.28% from a year prior.
  • Interest & Investment Income hit $4.2 million in Q1 2025 for Tandem Diabetes Care, down from $4.5 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $5.9 million in Q1 2023 to a low of -$47000.0 in Q4 2021.
  • Median Interest & Investment Income over the past 5 years was $3.1 million (2022), compared with a mean of $3.0 million.
  • Biggest five-year swings in Interest & Investment Income: tumbled 114.16% in 2021 and later soared 6687.23% in 2022.
  • Tandem Diabetes Care's Interest & Investment Income stood at -$47000.0 in 2021, then soared by 6687.23% to $3.1 million in 2022, then skyrocketed by 79.36% to $5.6 million in 2023, then decreased by 18.76% to $4.5 million in 2024, then decreased by 7.05% to $4.2 million in 2025.
  • The last three reported values for Interest & Investment Income were $4.2 million (Q1 2025), $4.5 million (Q4 2024), and $5.3 million (Q3 2024) per Business Quant data.